DONNA O'DANIEL: Open Payments
NPI 1811237415 · FRANKLIN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$218 in 12 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $93 · 2025 $218
Food & beverage: $218
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 2 | $44 |
| Lilly USA, LLC | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| Novo Nordisk Inc | 2 | $28 |
| ViiV Healthcare Company | 1 | $28 |
| Verona Pharma, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| PFIZER INC. | 1 | $17 |
Products named: Korlym, MOUNJARO, CAPLYTA, APRETUDE, Ohtuvayre, AREXVY, NURTEC ODT, Wegovy.
Industry payments across IN — which companies pay providers there.
